BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 27491084)

  • 1. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nucleolus as a Proteostasis Regulator.
    Amer-Sarsour F; Ashkenazi A
    Trends Cell Biol; 2019 Nov; 29(11):849-851. PubMed ID: 31473054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
    Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
    Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease.
    Prodromou C; Aran-Guiu X; Oberoi J; Perna L; Chapple JP; van der Spuy J
    Subcell Biochem; 2023; 101():389-425. PubMed ID: 36520314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular chaperone functions in protein folding and proteostasis.
    Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
    Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organismal Protein Homeostasis Mechanisms.
    Hoppe T; Cohen E
    Genetics; 2020 Aug; 215(4):889-901. PubMed ID: 32759342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.
    Tedesco B; Ferrari V; Cozzi M; Chierichetti M; Casarotto E; Pramaggiore P; Mina F; Galbiati M; Rusmini P; Crippa V; Cristofani R; Poletti A
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic atlas of chaperome deregulation topologies across the human cancer landscape.
    Hadizadeh Esfahani A; Sverchkova A; Saez-Rodriguez J; Schuppert AA; Brehme M
    PLoS Comput Biol; 2018 Jan; 14(1):e1005890. PubMed ID: 29293508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein homeostasis as a therapeutic target for diseases of protein conformation.
    Calamini B; Morimoto RI
    Curr Top Med Chem; 2012; 12(22):2623-40. PubMed ID: 23339312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-molecule modulation of cellular chaperones to treat protein misfolding disorders.
    Sloan LA; Fillmore MC; Churcher I
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):666-81. PubMed ID: 19736625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting DNA topoisomerases or checkpoint kinases results in an overload of chaperone systems, triggering aggregation of a metastable subproteome.
    Huiting W; Dekker SL; van der Lienden JCJ; Mergener R; Musskopf MK; Furtado GV; Gerrits E; Coit D; Oghbaie M; Di Stefano LH; Schepers H; van Waarde-Verhagen MAWH; Couzijn S; Barazzuol L; LaCava J; Kampinga HH; Bergink S
    Elife; 2022 Feb; 11():. PubMed ID: 35200138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chaperones as therapeutic targets to counteract proteostasis defects.
    Cattaneo M; Dominici R; Cardano M; Diaferia G; Rovida E; Biunno I
    J Cell Physiol; 2012 Mar; 227(3):1226-34. PubMed ID: 21618531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular responses to misfolded proteins and protein aggregates.
    Houck SA; Singh S; Cyr DM
    Methods Mol Biol; 2012; 832():455-61. PubMed ID: 22350905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding.
    Yakubu UM; Morano KA
    Biol Chem; 2018 Sep; 399(10):1215-1221. PubMed ID: 29908125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-Protein Interactions in the Molecular Chaperone Network.
    Freilich R; Arhar T; Abrams JL; Gestwicki JE
    Acc Chem Res; 2018 Apr; 51(4):940-949. PubMed ID: 29613769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.